Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
8,457
Price
$13.23
Total Value
$111,853.13
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Apr 30, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 1, 2026 |
| Shares Sold | 8,457 |
| Price per Share | $13.23 |
| Total Value | $111,853.13 |
| Shares Owned After | 423 |
| Derivative | No |
| Accession Number | 0001810417-26-000008 |
| Document | View SEC Filing |